335654-08-5

Basic information

• Product Name: 2-chloro-5H-pyrrolo[2,3-d]pyrimidin-6(7H)-one
• Synonyms: 2-chloro-5H-pyrrolo[2,3-d]pyrimidin-6(7H)-one;2-Chloro-5,7-dihydro-6H-p...;2-chloro-5H,6H,7H-pyrrolo[2,3-d]pyriMidin-6-one;2-chloro-1H-pyrrolo[2,3-d]pyrimidin-6(5H)-one;2-Chloro-5H-pyrrolo[2,3-d]pyrimidin-6(7H);2-chloro-5,7-dihydropyrrolo[2,3-d]pyrimidin-6-one
• CAS NO: 335654-08-5
• Molecular Formula: C₆H₄ClN₃O
• Molecular Weight: 169.57
• Product Categories: CHIRAL CHEMICALS
• Mol File: 335654-08-5.mol
• Article Data: 6

Chemical Properties

• Boiling Point: 479.5 °C at 760 mmHg
• Flash Point: 243.8 °C
• Appearance: /
• Density: 1.549 g/cm³
• Vapor Pressure: 2.35E-09mmHg at 25°C
• Refractive Index: 1.618
• Storage Temp.: under inert gas (nitrogen or Argon) at 2-8°C
• PKA: 10.24±0.20(Predicted)
• CAS DataBase Reference: 2-chloro-5H-pyrrolo[2,3-d]pyrimidin-6(7H)-one(CAS DataBase Reference)
• NIST Chemistry Reference: 2-chloro-5H-pyrrolo[2,3-d]pyrimidin-6(7H)-one(335654-08-5)
• EPA Substance Registry System: 2-chloro-5H-pyrrolo[2,3-d]pyrimidin-6(7H)-one(335654-08-5)

Safety Data

• Hazardous Substances Data: 335654-08-5(Hazardous Substances Data)

Usage

General Description

2-Chloro-5H-pyrrolo[2,3-d]pyrimidin-6(7H)-one is a chemical compound with a molecular formula of C6H3ClN2O. It is a pyrrolopyrimidine derivative with a chlorine atom attached to the second carbon of the pyrrole ring. 2-chloro-5H-pyrrolo[2,3-d]pyrimidin-6(7H)-one has potential pharmaceutical applications due to its structural resemblance to natural purine bases and its ability to interact with biological systems. It may be used in the synthesis of new drugs or as a starting material for the development of novel pharmacological agents. Additionally, it may have other industrial uses like in the manufacturing of specialty chemicals or as a research tool in the study of nucleic acids and nucleotides.

InChI:InChI=1/C6H4ClN3O/c7-6-8-2-3-1-4(11)9-5(3)10-6/h2H,1H2,(H,8,9,10,11)

Upstream product

• 335654-07-4 5,5-dibromo-2-chloro-5H-pyrrolo[2,3-d]pyrimidin-6(7H)-one 
• 335654-06-3 2-chloro-7H-pyrrolo[2,3-d]pyrimidine 
• 335654-05-2 2-chloro-5-(2-ethoxyvinyl)pyrimidin-4-amine 
• 335654-13-2 2-chloro-5-(2,2-dimethoxy-ethyl)-pyrimidin-4-ylamine 

Downstream Products

• 5817-96-9 5,7-dihydro-6H-pyrrolo[2,3-d]pyrimidin-6-one 
• 1360822-16-7 E/Z-2-chloro-5-(3-chloro-2-fluorobenzylidene)-5,7-dihydropyrrolo[2,3-d]pyrimidin-6-one 

Relevant articles and documents

cGAS ANTAGONIST COMPOUNDS

Disclosed are novel compounds of Formula (I) that are cGAS antagonists, methods of preparation of the compounds, pharmaceutical compositions comprising the compounds, and their use in medical therapy.

NOVEL SUBSTITUTED CONDENSED PYRIMIDINE COMPOUNDS

Novel substituted condensed pyrimidine compounds of general formula (I) in which the chemical groupings, substituents and indices are as defined in the description, and to their use as medicaments, in particular as medicaments for the treatment of conditions and diseases that can be treated by inhibition of the PDE4 enzyme.

New substituted spiro[cycloalkyl-1,3'-indo]-2'(1'H)-one derivatives and their use as p38 mitogen-activated kinase inhibitors

This invention is directed to new inhibitors of the p38 mitogen-activated protein kinase having the general formula (I) to processes for their preparation; to pharmaceutical compositions comprising them; and to their use in therapy.